Covered recipient · General Payments record
ADRIANA HOHL
General Payments · PY2018–2024
$1,575.16
- Reported across 81 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $229.55 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $57.22 | 3 |
| Phathom Pharmaceuticals, Inc. | $44.53 | 2 |
| ABBVIE INC. | $30.44 | 2 |
| Merck Sharp & Dohme Corporation | $27.26 | 1 |
| Medtronic, Inc. | $21.89 | 1 |
| Abbott Laboratories | $20.53 | 1 |
| GlaxoSmithKline, LLC. | $13.86 | 1 |
| Lilly USA, LLC | $13.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.53 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125373455 | CMS |
| ABBVIE INC. | $14.20 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103929168 | CMS |
| ABBVIE INC. | $16.24 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103929170 | CMS |
| GlaxoSmithKline, LLC. | $13.86 | 10/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116180051 | CMS |
| Lilly USA, LLC | $13.82 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135995182 | CMS |
| Medtronic, Inc. | $21.89 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116885926 | CMS |
| Merck Sharp & Dohme LLC | $27.26 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141811545 | CMS |
| Novo Nordisk Inc | $21.73 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108576549 | CMS |
| Novo Nordisk Inc | $15.35 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108577767 | CMS |
| Novo Nordisk Inc | $20.14 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108578497 | CMS |
| Phathom Pharmaceuticals, Inc. | $17.01 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151072858 | CMS |
| Phathom Pharmaceuticals, Inc. | $27.52 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151072860 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.